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Purpose: The study was conducted to evaluate the clinical results of resection for retroperitoneal soft tissue sarcoma (STS)
with vascular involvement.
Methods: The study group consisted of consecutive patients (mean age, 52 years) who underwent surgery for retroperi-
toneal STS with vascular involvement. The procedures were performed between 1988 and 2004. Vessel involvement by
STS was classified as type I, artery and vein; type II, only artery; type III, only vein; and type IV, neither artery nor vein
(excluded from the analysis). Patient data were prospectively gathered in a computerized database and retrospectively
analyzed.
Results: Of 141 patients with retroperitoneal STS, 25 (17.7%) underwent surgery for tumors with vascular involvement.
The most common vascular involvement pattern was vein only (type III) at 64%. Arterial and vein (type I) and arterial
only (type II) involvement were observed in 16% and 20% of the cases, respectively. STS originating from the vessel wall
(primary vessel involvement) was seen in eight patients, and 17 patients had secondary vascular involvement. Resection
and vascular repair were done in 22 patients (no vascular repair in three patients due to ligation of the external iliac vein
in one patient, and debulking procedures in two). All patients with arterial involvement (type I and II) had arterial
reconstruction consisting of aortic replacement (Dacron, n  3; and expanded polytetrafluoroethylene [ePTFE], n  2),
iliac repair (Dacron, n  3), and truncal reimplantation (n  1). The inferior vena cava (6 ePTFE tube grafts, 3 ePTFE
patches, 2 venoplasties), iliac vein (1 ePTFE bypass, 1 Dacron bypass, 1 venous patch), and superior mesenteric vein (1
anastomosis, 1 Dacron bypass) were restored in 80% of the patients (n  16) with either arterial and venous or only
venous involvement (type I and type III setting). Morbidity was 36% (hemorrhage, others), and mortality was 4%. At a
median follow-up of 19.3 months (interquartile range, 12.8 to 49.9 months) the arterial patency rate was 88.9%, and the
venous patency rate was 93.8% (primary and secondary). Thrombosis developed in one arterial and venous (type I) iliac
reconstruction due to a perforated sigmoid diverticulitis 12 months after surgery. The local control rate was 82.4%. The
2-year and 5-year survival rates were 90% and 66.7% after complete resection with tumor-free resection margins (n  10
patients, median survival not reached at latest follow-up). The median survival was 21 months in patients with complete
resection but positive resection margins (n  7) and 8 months in patients with incomplete tumor clearance (n  8,
persistent local disease or metastasis).
Conclusions: Patency rates and an acceptable surgical risk underline the value of en bloc resection of retroperitoneal STS
together with involvement of blood vessels. The oncologic outcome is positive, especially after complete resection with
tumor-free resection margins. A classification of vascular involvement can be used to plan resection and vascular
replacement as well as to compare results among reports in a standardized fashion. (J Vasc Surg 2006;44:46-55.)Recently, 77% of retroperitoneal sarcoma-related
deaths were shown to be caused by local recurrence without
concomitant metastasis.1 Local control is therefore impor-
tant in the treatment of adult patients with retroperitoneal
soft tissue sarcoma (STS). Surgery is the mainstay of treat-
ment.2,3 In contrast, effective adjuvant chemotherapy reg-
imens have not been identified yet, and radiotherapy is
limited because of the toxicity to healthy adjacent struc-
tures.4
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46In a subset of patients, retroperitoneal STS involves
major venous or arterial blood vessels.5–13 In this clinical
setting, sarcoma surgery represents a challenge in terms of
treatment concept and technique. Planned vascular resec-
tion is essential to meet the oncologic standards of a com-
plete tumor resection with microscopically negative resec-
tion margins and the prevention of tumor laceration during
surgery.14 –16 Furthermore, detailed analysis has shown
that only few clinical data are available to answer the
question of how blood vessel involvement influences re-
sectability, surgical approach, and the further course of the
disease.5–13 Owing to the restricted number of clinical
series and the lack of multi-institutional or national regis-
tries, the significance of blood vessel involvement by retro-
peritoneal STS is not understood very well.
The aim of this study was to assess vascular involvement
in retroperitoneal STS, to suggest a treatment algorithm,
and to analyze the results of retroperitoneal sarcoma sur-
gery that requires vascular resection. Immediate-term and
is re
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coma surgery performed during a 17-year period.
METHODS
Inclusion criteria. Consecutive adult patients treated at
the University of Heidelberg Department of Surgery from
January 1988 to December 2004 with the diagnosis of retro-
peritoneal STS involvingmajor blood vessels were included in
the analysis. Tumors were studied preoperatively by ultra-
sonography, magnetic resonance imaging (MRI), or com-
puted tomography (CT), or a combination of these, with or
without angiography.17–20 The indications for STS resection
en bloc together with major blood vessels were standardized
and applied in patients with clear involvement of major blood
vessels. Vascular involvement was diagnosed when MRI or
CT scans did not show a rim of normal tissue in the tumor-
to-vessel interface. One pathologist (G. M.) assessed the re-
sected specimens histopathologically. Grade was determined
by the degree of cellularity, differentiation, pleomorphism,
necrosis, and mitotic activity and categorized into low-grade,
intermediate-grade, and high-grade STS.15
Definitions. Primary tumorwas defined as the initially
diagnosed mass, including previously biopsied or incom-
pletely resected lesions 12 weeks after the initial diagno-
sis. Locally recurrent disease was defined as the develop-
ment of a mass of the same histologic subtype after prior
complete resection. The clinical setting in which tumors
originate from the vessel wall was considered primary blood
vessel involvement. A tumor invading or embracing the
vessel wall was referred to as secondary vessel involvement.
Complete resection was defined as the removal of all
macroscopic disease, subdivided into complete resection
with histologically negative margins and histologically pos-
itive margins. Incomplete resection (debulking) was defined
as the removal of more than half of the tumor mass;
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Classification of vascular involvement. Types of vas-
cular involvement were assessed preoperatively by high-
resolution CT scans or MRI.
Primary and secondary vessel involvement are indistin-
guishable by preoperative radiologic tomography or by
clinical assessment. Therefore, both primary and secondary
blood vessel involvement were classified as follows: type I,
STSs involving major arteries and veins; type II, STSs
affecting only arterial blood vessels; type III, sarcomas
involving the veins without altering an artery; type IV, STSs
without direct involvement of arterial or venous blood
vessels (Fig 1). This classification of vascular involvement
for retroperitoneal
in the extremities.21
STSs was introduced previously for STSs
Surgery, radiation, and vascular replacement. STSs
were resected en bloc together with blood vessels according
to the type of vascular involvement and the surgical stan-
dards.15,21 An interdisciplinary tumor conference was es-
tablished to evaluate whether additional therapeutic mo-
dalities such as radiotherapy or chemotherapy were
required.22 Radiotherapy was given in higher-grade and
recurrent STSs according to an intraoperative and postop-
erative protocol, but only intraoperatively in patients who
had received radiation treatment previously or selectively as
an external beam radiotherapy.23,24 Radiosensitive struc-
tures such as ureter or small bowel were spared from
intraoperative radiation by dissection, mobilization, and
positioning of the collimation tube.24
Blood flow was restored with respect to the resection
site and the extent of the vascular defect and collateral
blood flow (e.g., venous drainage). Arterial reconstructions
were usually performed by the appropriate method, such as
primary anastomosis, reinsertion, or synthetic prostheses
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versed great saphenous vein) was not routinely used for
arterial repair; however, it was considered in selective cases
(visceral or iliac arteries). Circular venous defects of the
inferior vena cava were reconstructed by ePTFE prostheses
when a primary anastomosis was impossible. For localized
defects of the inferior vena cava, either a synthetic or a
venous patch was used or venoplasty (longitudinal suture)
was performed. Veins occluded by thrombosis were not
reconstructed (ligation of the proximal and distal venous
stump).
Patients routinely received prophylactic antibiotic
treatment (cephalosporin) both preoperatively and postop-
eratively. Bowel preparations were not routinely adminis-
tered. Silver-containing prostheses or grafts with antibiotic
pretreatment were preferred in case of large bowel resec-
tion. Subsequent to intestinal anastomosis, gloves were
changed and protecting towels as well as instruments re-
placed. Perioperatively, a low-dose regimen of heparin was
administered (unfractionated heparin intraoperatively and
low-molecular-weight heparin in the postoperative phase).
After discharge, oral anticoagulants (phenprocoumon)
were not routinely administered.
Patient population. A total of 141 adult patients with
retroperitoneal STS had surgery. In 25 of these patients,
the STS involved major retroperitoneal blood vessels
(17.7%). Themedian patient age was 52 years (interquartile
range [IQR], 18 to 82 years), and 13 women and 12 men
were treated. Various unspecific symptoms such as pain,
loss of weight, or urinary obstruction were recorded (Table
I). Vascular complications such as venous obstruction with
lower limb edema or arterial occlusion (claudication) were
rare (Table I).
In all, 18 patients (72%) were referred for primary STS
and seven patients (28%) for local recurrence. One patient
was diagnosed with the first, three with the second, two
with the third, and one with the fourth local recurrence.
Four patients (16%) had concomitant disseminated disease
(Table I). The most common histologic diagnosis was
leiomyosarcoma, followed by liposarcoma, malignant fi-
brous histiocytoma, and clear cell sarcoma (Table I); of
these, 68% were high-grade STS, 20% intermediate-grade
tumors, 8% low-grade, and 4% could not be classified. Most
of the lesions were large, with a tumor diameter of 7 cm
(Table I). Intraoperative radiotherapy combined with post-
operative radiation was administered to 24% of the patients,
and 12% received postoperative radiotherapy only. Chemo-
therapy was administered postoperatively to four patients
and perioperatively to three patients (with radiation in one
patient).
Arterial reconstruction. Arterial repair was done in
nine patients, consisting of five aortic reconstructions, one
reimplantation of the celiac trunk into the aorta, and three
iliac reconstructions. In two patients, the resected infrare-
nal aorta (with ligation of the inferior mesenteric artery)
was replaced by straight tube grafts, one 16-mm Dacron
graft (Gelsoft®, Vascutek, Renfrewshire, Scotland, UK)
and one 16-mm ePTFE prosthesis. In another patient, a6-mm ePTFE axillobifemoral bypass was implanted after
resection of the infrarenal aorta.
A thoracoabdominal incision was required in two pa-
tients. One of these patients was treated with an 18-mm
Hemashield® (Boston Scientific, La Garenne Colombes,
Cedex, France) straight tube Dacron graft for bridging a
thoracoabdominal defect. To preserve the spinal cord
blood supply, a segmental costal artery was reconnected to
the aorta by a venous bypass. The second thoracoabdomi-
nal aortic defect was reconstructed with a 16-mm Dacron
straight Silver® (InterGard, La Ciotat, Cedex, France)
prosthesis. One patient was treated by reimplantation of the
celiac artery into the aorta. In the iliac arteries, reconstruc-
tion consisted of three 8-mm Dacron anatomic ileoileal
tube grafts for interposition of the common iliac artery, the
external iliac artery, and the internal iliac artery. In Table II,
the arterial reconstructive procedures are summarized ac-
cording to the type of vascular involvement.
Venous reconstruction. Venous repair consisted of
reconstruction of the inferior vena cava in 11 patients, the
iliac vein in three patients, and the superior mesenteric vein
in two patients. In six patients, 16-mm to 20-mm ePTFE
prostheses were used to bridge the caval defects. The left
renal vein also had to be replaced with an 8-mm ePTFE
Table I. Clinicopathologic factors in 25 patients with
soft tissue sarcomas of the retroperitoneum involving
major blood vessels
Characteristics Total (n  25) Rate (%)
Symptoms
Pain 15 60
Weight loss 5 20
Limb edema 3 12
Urinary stasis 4 16
Claudication 1 4
Presentation status
Primary tumor 16 64
Local recurrence 5 20
Primary tumor and metastasis 2 8
Local recurrence and metastasis 2 8
Histologic type
Leiomyosarcoma 12 48
Liposarcoma 4 16
Malignant fibrous histiocytoma 2 8
Clear cell sarcoma 2 8
Malignant paraganglioma 1 4
Angiosarcoma 1 4
Malignant hemangiopericytoma 1 4
Ewing’s sarcoma 1 4
Unclassified sarcoma 1 4
Tumor size [cm]
7 8 32
7 to 12 12 48
12 5 20
Tumor grade*
Low 2 8
Intermediate 5 20
High 17 68
*One tumor could not be graded.prosthesis in one of these cases. A partial wall defect of the
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patients and by venoplasty in two patients. Two reconstruc-
tions of the common iliac vein consisted of one 8-mm
ePTFE bypass and one venous patch (contralateral great
saphenous vein). The internal iliac vein was reconstructed
by a Dacron graft in one patient. Two superior mesenteric
vein reconstructions were accomplished by direct end-to-
end anastomosis in one and by a Dacron bypass in one. One
patient with resection of the iliac vein was not recon-
structed due to massive scarring from previous operations.
The different venous reconstructive procedures are summa-
rized in Table II according to the type of vascular involve-
ment.
Follow-up. Patients were seen regularly during the
observation period at our outpatient clinic. The standard
vascular follow-up was at 6 weeks and 6 months postoper-
atively and yearly thereafter. Patients were also seen accord-
ing to the routine oncologic follow-up schedule. They were
questioned about symptoms suggesting graft thrombosis,
including pain and discomfort. Clinical examinations were
usually combined with duplex ultrasonography to evaluate
the patency of arterial and venous reconstructions. In ad-
dition, CT or MRI follow-up examinations for tumor stag-
ing were used to assess the patency of arterial and venous
reconstructions.
Statistical analysis. SAS 9.1 software (SAS Institute,
Inc, Cary, NC) was used for statistical analysis. The distri-
bution of age at operation and tumor size as well as
follow-up time were described as the median with an IQR.
Kaplan-Meier estimations were used to analyze the survival
rates from the date of surgery.25 The 2-year and 5-year rates
with a corresponding 95% confidence interval (CI) were
presented for overall survival. Patients in whom no event
was observed were censored at the last follow-up. The
Table II. Reconstruction and graft material according to
retroperitoneal soft tissue sarcomas
Vascular reconstruction
(n  22)
Type I (n  4)
Artery
ePTFE prosthesis 2
axillofemoral (1)
aortic (1)
Dacron prosthesis 2
iliac (2)
e PTFE patch —
Venous patch —
Venoplasty —
Reimplantation —
Anastomosis —
ePTFE, Expanded polytetrafluoroethylene; SMV, superior mesenteric vein.log-rank test was performed to compare survival time dis-tributions between curves regarding margin of resection.
Two-sided P values were always computed, and an effect
was considered statistically significant at P  .05.
RESULTS
Resectability and vascular infiltration. In 25 pa-
tients who underwent surgery, resection was complete in
17 patients (68%). Surgery did not clear all macroscopic
disease in eight patients (32%), either because of distant
metastasis in six, including patients with subsequent resec-
tion of metastasis, or because of residual disease at the site
of resection in two (Table III). Vascular resection was
performed in 23 patients (92.0%). Two patients were not
treated by vascular resection, one of whom was diagnosed
ype of vascular involvement in 22 patients with
Type II (n  5)
Artery
Type III (n  13)
Vein
— 5 caval (5)
1)
(1)
4 1
1) aortic (3) mesenteric (SMV) (1)
iliac (1)
— 3
caval (3)
— 1
iliac (1)
— 2
caval (2)
1 —
coeliac trunk
(1)
— 1
mesenteric (SMV) (1)
Table III. Resectability of retroperitoneal soft tissue
sarcomas with blood vessel involvement in 25 patients
Characteristics Total (n  25) Rate (%)
Resectability
Complete resection 17 68
With negative margin 10 40
With positive margin 7 28
Incomplete resection 8 32
Vascular resection
Artery 5 20
Vein 14 56
Artery and vein 4 16
None 2 8
Vessels resected
Inferior vena cava 12 48
Iliac vein 4 16
Mesenteric vein 2 8
Aorta 6 24
Iliac artery 3 12
None 2 8the t
Vein
2
iliac (
caval
1
iliac (
—
—
—
—
—with a primary leiomyosarcoma of the inferior vena cava,
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the heart. The other patient presented with an unclassified
large and infiltrating sarcoma of the inferior vena cava (27
cm in diameter) (Table III). Adherent organs or structures
were resected in 11 (44%) of 25 patients; kidney (n  6),
large bowel (n 3), and small bowel (n 3) were the most
commonly resected organs. Two patients each had chole-
cystectomy, omentectomy, and liver resection.
Resection was performed for four (16%) STSs with
arterial venous involvement (type I), in five (20%) with only
arterial involvement (type II), and in 16 (64%) with only
venous involvement (type III) (Fig 1). Histopathologic
examination of the specimens showed that eight (32%)
STSs originated in the blood vessel wall, including seven
leiomyosarcomas of the inferior vena cava and one angio-
sarcoma of the aortic wall (Table IV). All of the latter STSs
were primary tumors and predominantly classified as high-
grade lesions, and 17 (68%) secondarily involved major
vessels. Of these, 11 sarcomas had infiltrated the vessel wall
(four showed both arterial and venous infiltration, six ve-
nous infiltration only, and one arterial infiltration only)
(Table IV). In the other six STSs with secondary involve-
ment, vessel encasement without infiltration was observed.
Diverse histologic subtypes (e.g., liposarcoma, malignant
fibrous histiocytoma, and clear cell sarcoma) and either
primary disease (n  10) or locally recurring tumors (n 
7) were diagnosed for secondary vascular involvement (Ta-
ble IV). Tumor growth also affected adjacent retroperito-
neal or visceral organs. Of 11 patients in whom organs were
resected, six presented with organ infiltration on his-
topathologic examination: kidney, 3; small bowel, 2; pan-
creas, 2; and 1 each large bowel, liver and spleen.
Morbidity and mortality. Morbidity was observed in
nine (36%) of 25 patients. Hemorrhage (16%) was the most
common complication.Wound infection, prolonged bowel
dysfunction, ureter stenosis, neurologic deficit, or abscess
Table IV. Results of histopathologic evaluation of the
surgical specimen concerning vascular and organ
involvement in 25 patients with retroperitoneal soft tissue
sarcomas
Characteristics Total* (n  25) Rate (%)
Primary involvement 8 32
Vascular origin 8 32
Artery (type II) 1 4
Vein (type III) 7 28
Secondary involvement 17 68
Vascular infiltration 11 44
Artery and vein (type I) 4 16
Artery (type II) 1 4
Vein (type III) 6 24
Vascular encasement 6 24
Artery and vein (type I) 0 0
Artery (type II) 3 12
Vein (type III) 3 12
*Includes two patients with incomplete resectionoccurred in 4% of the cases, respectively. All patients withwound infections were successfully treated conservatively,
as was one patient with postoperative bleeding. Two pa-
tients with hemorrhage required revision surgery, leading
to a reoperation rate of 8%. A thromboembolic complica-
tion and anastomotic leakage associated with blood vessel
reconstruction were observed in one patient each.
The mortality rate was 4% owing to the death of one
patient on the first postoperative day from massive intraop-
erative blood loss with subsequent multiorgan failure. In
this patient, a large recurrent retroperitoneal tumor invad-
ing the infrarenal aorta, common iliac vessels, and inferior
vena cava (type I) was resected together with adjacent
organs. After ligation of the vena cava and aorta, an axillo-
bifemoral bypass was implanted.
Arterial resection and graft function. Nine (36%) of
the 25 patients were treated by arterial resection. Four
arterial resections (16%) were performed for STSs that
involved both arteries and veins (type I), and five arterial
resections (20%) were for tumors that only involved arteries
(type II). All arterial resections were followed by vessel
reconstruction. In eight (88.9%) of nine reconstructions,
synthetic grafts were used, and one reimplantation of the
celiac trunk was done.
No patient was lost to follow-up. Median follow-up
was 19.3 months for surviving patients (IQR, 12.4 to 49.9
months). The overall patency rate of arterial reconstruc-
tions was 88.9% (8 of 9 reconstructions).
Graft infection with septic thrombosis was diagnosed in
one patient 12 months after surgery for a STS that involved
the iliac artery and vein (type I). The underlying cause of
late graft infection of the iliac prostheses (Dacron for
arterial repair and ePTFE for venous repair) was a perfo-
rated sigmoid diverticulitis. Treatment consisted of explan-
tation of the iliac grafts, ligation of the iliac vein, and
implantation of a Dacron extra-anatomic femorofemoral
bypass for arterial repair.
Venous resection and graft function. Twenty pa-
tients (80%) had venous involvement: four with arterial
involvement also (type I STS) and 16 with only venous
involvement (type III). In two cases, extensive tumor
growth precluded venous resection. Venous resection was
used in 18 patients (72%), four for type I involvement
(16%) and 14 for type III involvement (56%). In the
patients with both arterial and venous involvement, three
venous resections (75%) were followed by venous recon-
struction. In one patient with a pre-existing thrombotic
occlusion of the inferior vena cava, only arterial repair was
done. Resections were reconstructed in 13 of the patients
(92.9%) with venous involvement alone. In one patient
with resection of the external iliac vein, the vessels could
not be reconstructed because of massive scarring in the
operation field. Of the 18 patients with venous involvement
and resection, venous repair was completed in 16 cases
(88.9%).
One venous graft thrombosis occurred because of a
perforated sigmoid diverticulitis, as described previously.
Treatment consisted in explantation of the iliac ePTFE
graft with ligation of the iliac vein. The venous ligation was
9.3 m
nths
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mild limb edema at themost recent follow-up. Thus, all but
one of the venous reconstructions (93.8%) remained patent
during the observation period.
Tumor control and survival. After complete tumor
resection, three of 17 patients presented with local recur-
rences (local tumor control rate, 82.4%). One (16.7%) of
six patients who underwent debulking surgery was diag-
nosed with local tumor progression. At the last follow-up,
14 patients (56%) were alive (Fig 2). According to the type
of vascular involvement, 25% (1 of 4) of the patients with
Fig 2. Disease-specific survival of all patients after rese
involvement (25 patients). The median follow-up was 1
Fig 3. Disease-specific survival after complete resectio
microscopically positive resection margin, and debulking
major blood vessels. The median follow-up was 19.3 motype I STS survived during the observation period, and 60%(3 of 5) of the type II and 62.5% (10 of 16) of the type III
patients were alive at the latest follow-up. In the group of
patients with complete tumor resection, 13 (68%) survived
and six (32%) died because of metastatic or local recurrent
disease.
After complete resection with negative resection mar-
gins, the 2-year and 5-year survival rates were 90% and
66.7% (Fig 3). Patients diagnosed with macroscopically
complete resection and positive resection margins pre-
sented with a median survival of 21 months. In the noncu-
rative group (persistent local disease or metastasis), two of
of retroperitoneal soft tissue sarcoma with blood vessel
onths (interquartile range, 12.8 to 49.9 months).
h negative resection margin, complete resection with
ry in 25 patients with retroperitoneal sarcoma involving
(interquartile range, 12.8 to 49.9 months).ctionn wit
surgethe patients were alive at the latest follow-up. The respec-
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(Fig 3). Univariate analysis determined that the margin of
resection (complete resection with negative margin vs com-
plete resection with positive margin vs incomplete resec-
tion, P  .0034) was a significant prognostic factor for
survival.
DISCUSSION
Although complete resection is the mainstay of the
treatment,26 –28 a systematic review showed that only 53%
of the patients who underwent surgery for retroperitoneal
STSs were treated by complete resection.29 Removing sur-
rounding organs (e.g., kidney, colon, small bowel), if nec-
essary by multivisceral resection, contributes to an im-
proved resectability rate.26,30 In a subset of patients,
however, organ resection alone is not sufficient. An STS
that involves major retroperitoneal blood vessels, such as
the inferior vena cava, aorta, or iliac, or visceral vessels
requires planned vascular resection.3 Resectability rates of
80% to 100% have previously been reported in patients with
vascular involvement in extremity sarcomas.21,31,32 By de-
liberately sacrificing retroperitoneal vascular structures,
sharp dissection of the vessels becomes redundant, and the
margins as well as resectability can be improved.
The number of patients with retroperitoneal STSs re-
quiring major vascular resections is unknown. In the
present analysis of a consecutive series, the frequency of
retroperitoneal vascular involvement, at 17.7%, was consid-
erable. In addition to leiomyosarcomas and liposarcomas,
diverse other types of sarcomas were associated with vascu-
lar involvement.33 Most studies, however, focus selectively
on the very rare entity of primary leiomyosarcoma of the
vena cava, neglecting all other sarcomas that involve blood
vessels in the retroperitoneum.5,6,7,9,11,34 –36
Our data show that most of the STSs secondarily in-
volved vascular structures either by histologically proven
vascular infiltration or by vascular encasement (Table IV).
Only a few patients were noted with tumors originating
from retroperitoneal blood vessels such as the caval leiomy-
osarcoma. Retroperitoneal sarcomas are usually large at
diagnosis, and the differentiation between primary or sec-
ondary blood vessel involvement is not made before the
pathologist examines the specimen.15 This clinical situation
implicates that the latter occurrences have to be treated by
a common procedural algorithm and resection strategy.11
Here, we suggest a novel, four-stage classification that
describes the pattern of vascular involvement by retroperi-
toneal STSs. This analysis clearly demonstrates that the
most common type of vascular involvement is type III,
venous involvement (Fig 1). This pattern also predomi-
nates in the literature, explained in particular by the large
number of reports about leiomyosarcomas of the inferior
vena cava (Table V).5,6,9 –11 In type III tumors, surgery
usually has to be performed on the vena cava or iliac veins
(Tables II and V).5,6,9 –11
The present analysis also shows that isolated arterial
involvement by retroperitoneal sarcomas (type II) occurs
with a lower frequency (Fig 1). Chiche et al12 reported onfive patients with sole arterial growth pattern, representing
the largest series apart from ours (Table V). Type II sarco-
mas especially impact on the aorta or the iliac arteries and
uniformly require vascular reconstruction (Tables II and
V).7,12 Also less common, as shown here, is the simulta-
neous involvement of retroperitoneal arteries and veins by
type I sarcomas (Fig 1).
Data on type I tumors have only been supplied by
Dzsinich et al,5 who reported on one (7.7%) of 13 leiomy-
osarcomas with both arterial and venous involvement . The
analysis by Zheng et al8 does not distinguish type I sarco-
mas by numbers, although both retroperitoneal arteries
and veins were replaced.
Simultaneous arterial and venous resection in the ret-
roperitoneum mainly concerns the aortoiliac or iliocaval
vessels (Tables II and V).7,8 The respective vascular recon-
structive algorithm depends on the type of vascular involve-
ment and the prevalence of venous thrombosis, which per
se makes venous reconstruction redundant (Fig 1).
The decision of whether to resect blood vessels depends
especially on preoperative radiologic imaging results.15,21
CT angiography with a four-detector system is sufficient as
the standard diagnostic procedure and can provide all the
relevant data needed for planned vascular resection.15 An-
other option is contrast-enhanced MRI using a standard
magnetic field strength of 1.5 Tesla.15,18 –20 In patients
with palpable pulses, routine angiography or MR angiog-
raphy is not necessary, and venography is usually not re-
quired.18 –20 Intravascular ultrasound scans can be used as a
complementary diagnostic tool. The value of positron
emission tomography is unclear.37,38
Arterial replacement was usually accomplished by im-
planting a synthetic vascular prosthesis in anatomic posi-
tion. Reconstructions are required, especially for aortic or
the iliac repair. Straight 16-mm to 18-mm tube grafts
(Gelsoft®, Hemashield®, or Silver®) are appropriate for
aortic reconstruction. Straight 8-mm Dacron prostheses
can be used for the iliac arteries. Visceral arteries have to be
resected for tumors extending into the mesenteric root. In
such cases, reconstruction can necessitate primary anasto-
mosis, reinsertion, or bridging by small-diameter grafts
(e.g., great saphenous vein, synthetic 6-mm ePTFE, or
Dacron prostheses). Good long-term patency rates (88.9%)
were observed in this analysis (Table V) when preferably
synthetic grafts were used for arterial reconstructions. Apart
from case reports, arterial bypass grafting after sarcoma
surgery has only been recognized in the literature in few
series (Table V).12,39
Central venous repair after resection prevents lower-
limb edema and the clinical sequelae such as pain, swelling,
tension, and skin alterations.40 Expanded PTFE (16 mm to
20mm) tube prostheses or ePTFE patches are preferred for
reconstruction of the inferior and middle portion of the
vena cava. Only in case of pre-existing venous thrombosis
should caval ligation be done below the renal veins or in the
iliac veins. If renal vein resection is necessary, reimplanta-
tion or bridging by a small-diameter graft (vein or synthetic
graft) can become necessary. Venoplasty is used for recon-
Table V. Literature review of clinicopathologic data and results in patients undergoing surgery for retroperitoneal soft tissue sarcoma involving major blood vessels
Author Cohort Histopathologic and clinical tumor characteristics Vascular reconstruction (region / method) Clinical results
Reference Years studied
No. of
patients/
STS Histology Grade Size (cm)
Primary/
recurrent
tumor Type
Graft
location Arterial repair Venous repair Morbidity/mortality
Follow-
up
(months)
Arterial/Venous
patency
Local/distant
recurrence Survival
Dzsinich
19925
1957-1990 13 / 13 13 LMS NS NS 12/1 1 Type I 6 IVC 1 2 ePTFE BP 2/13 (15%)/ NS NS 2/13 (15%)/ l5/13(38%)†
12 Type III 1 IV 1 Dacron-patch 1/13 (7.5%) 5/7 (71%) 5/13 (38%)
1 IA 1 venous BP
3 suture
Dong
19986
1990-1997 11/9 5 LMS 12-30 11 Type III 9 IVC 0 NR suture 3/11 (27%)/ 6 NS NS 11/11(100%)†
1 FS 1 IVCRV NR anastomosis 0/11 (0%) all repairs patent
1 MS 1 RV NR ligation
1 MP
1 MM
1 seminoma
1 CA
Babatasi
19987
NS 3/3 3 LMS 3 h.g. NS 3/0 1 Type II 1 IVC 1 synthetic BP 1 venous BP 0/3 (0%) NS 1/1 (100%)/ 1/3 (33%)/ 1/3(33%)†
1 Type III 1 PA 1 HT 0/3 (0%) 1/1 (100%) 1/3 (33%)
1 atrial
Zheng
19988
NS 25 / 13 6 LMS NS NS NS NS 12 IA 7 suture 8 suture 0/25 (0%)/ NS 16/16 (100%) NS 25/25(100%)†
4 LS 8 IV 6 ven./syn.BP 5 vein/synth.BP 0/25 (0%) 18/18 (100%)
1 NFS 6 IVC 3 anastomosis 5 anastomosis
2 FS 3 AO 1 ligation 4 ligation
1 teratoma 7 others
11 benign
Ridwelski
20019
1993-1999 5/5 5 LMS 2 l.g. 5-7 5/0 5 Type III 4 IVC NS 3 ePTFE-Patch 0/5 (0%) NS 0/5 (0%)/ 3/5(60%)†
2 i.g. 1 inoperable 1 NS 0/5 (0%) 3/3 (100%) 2/5 (40%)
1 NS
Arii
200310
1990-2001 11/1 1 LMS NS 3-15 8/3 11 Type III 11 hep. IVC 11 ePTFE 1/11 (9%) NS 6/11 (55%)/ 25.5%*
3 HCC 0/11 (0%) 11/11 (100%) 2/11(18%)
4 CC
3 metastasis
Hollenbeck
200311
1982-2002 25 / 25 25 LMS 25 h.g. 12 25/0 21 Type III 21 IVC 11 ligation 4/25 (16%)/ 24 NS/ 7/25 (33%)/ 33%*
7 suture 2/25 (8%) NS 10/25(48%)
2 ePTFE BP
1 venous patch
Chiche
200312
1990-2000 5/5 1 LMS NS NS 5/0 5 Type II 5 AO 6 synthetic BP 2/5 (40%)/ NS 6/7 (86%)/ 0/5 (0%)/ 8%*
1 MHE 2 AO/
SMA
1 venous BP 1/5 (20%) NS 1/5 (20%)
2 intimal
1 NS
Present
series
1988-2004 25 / 25 12 LMS 2 l.g. 10.5 18/7 4 Type I 11 IVC 6 Dacron BP 7 ePTFE BP 9/25 (36%)/ 19,3 8/9 (89%) 3/9 37.7*
4 LS 5 i.g. 5 Type II 3 IV 2 ePTFE BP 3 ePTFE patch 1/25(4%) NS
2 MFH 17 h.g. 16 Type III 2 SMV 1 reinsertion 1 venous patch
2 CCS 1 NS 6 AO 2 Dacron BP
5 STS 3 IA 2 venoplasty
1 anastomosis
2 ligation
NS, Not specified; NR, numbers not reported; STS, soft tissue sarcoma; LMS, leiomyosarcoma; LS, liposarcoma; MFH, malignant fibrous histiocytoma; CCS, clear cell sarcoma; MHE, malignant hemangioendothelioma; FS, fibrous sarcoma; NFS,
neurofibrosarcoma;MS, malignant schwannoma; ES, Ewing’s sarcoma;MP, malignant paraganglioma;MM, malignant mesenchymoma; BP, bypass; CA, carcinoma; LR, local recurrence; DR, distant recurrence; PT, primary tumor; IVC, inferior vena cava;
IV, iliac vein; SMV, superior mesenteric vein; IA, iliac artery; RV, renal vein; PA, pulmonary artery; HT, heart transplantation; SMA, superior mesenteric artery; AO, aorta.
*5-year-survival rate.
†Absolute number of survivors.
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July 200654 Schwarzbach et alstruction of localized venous wall defects if the residual
blood vessel diameter remains 70%. With respect to the
literature, here we report the largest series of patients with
retroperitoneal venous reconstructions after STS resec-
tion.5–12
We do not support the procedural concept of caval
ligation as reported by Hollenbeck et al.11 These authors
presented data on 25 resected leiomyosarcomas with caval
ligation in 11 cases (44%).11 Routine ligation of the infra-
renal vena cava should be reserved for emergent situations
(eg, massive hemorrhage or stool contamination) or pre-
existing venous thrombosis. The excellent venous patency
rate of 93.8% as observed in this series (Table V) sustains
the concept of venous repair.
The morbidity and reoperation rates in our study were
acceptable and thus further underline the concept of vas-
cular resection with consecutive repair (Table V).5–12
Bleeding was the most common complication; therefore,
careful hemostasis and cautious intraoperative administra-
tion of heparin are mandatory. Because patients usually
have an excellent peripheral run off, low-dose hepariniza-
tion is sufficient.
The use of prosthetic vascular grafts after multivisceral
resections or bowel surgery was not associated with an
increased infectious morbidity as shown by our results. In
case of large bowel resection, Silver® prostheses or grafts
pretreated with antibiotics are recommended. Bowel resec-
tion should be performed without contamination of the
abdominal cavity by using a separate set of instruments,
gloves, towels, and a linear stapler with cutting device
(GIA, Ethicon–Endosurgery, Inc., Cincinnati, OH). In
case of major abdominal contamination, extra-anatomic
arterial reconstruction as well as venous ligation has to be
considered.
The 2-year and 5-year survival rates of 90% and 66.7%
after complete resection with tumor-free resection margins
were rewarding (Fig 3). Taking into consideration that
most of the tumors showed adverse prognostic criteria such
as vascular involvement, higher grade, deep subfascial loca-
tion, or large size, these results are respectable (Table I and
Fig 3). Patients in our series with retroperitoneal vascular
involvement and positive resection margins were found to
have a less favorable prognosis (median survival after 20
months). Poor oncologic outcome (median survival, 8
months) was observed in patients who could not be treated
by complete resection.
Although a clinical benefit of improved survival and
palliation of symptoms has been reported for incomplete
resection of retroperitoneal liposarcoma by Shiabata et al,41
its advantage is questionable in patients with vascular in-
volvement. Local recurrence rates in this series are compa-
rable with the results presented in the literature (Table V).
Data from own observational analyses and from the
literature indicate that intraoperative radiotherapy, which
was applied in selectively in our patients, improves local
tumor control.23,24 There is evidence in favor of adjuvant
chemotherapy; however, this is still an individual and inter-
disciplinary decision.22 Owing to the restricted numbers ofpatients in the respective vascular involvement subgroups
(type I to type III) and the exclusion of type IV STS from
this analysis, a prognostic assessment of the proposed strat-
ification system can not done at this point of the analysis.
CONCLUSION
This analysis shows that complete resection with clear
margins is important for long-term survival in patients with
retroperitoneal soft tissue sarcomas. The use of vascular
resection is the treatment of choice in sarcomas that involve
major blood vessels in the retroperitoneum. With this tech-
nique, most patients with vascular involvement can be
treated by complete resection with tumor-free resection
margins. Primary sarcomas or local recurrences as well as
tumors with primary vascular involvement (eg, leiomyosar-
coma of the vena cava) or secondary vascular involvement
(eg, caval infiltration by a retroperitoneal liposarcoma)
require resection of diseased blood vessels. The extent of
vascular resection and the appropriate vascular repair has to
be assessed in the individual patient. The proposed classifi-
cation and treatment algorithm can be used to plan resec-
tion and vascular replacement. Finally, the categorization
of blood vessel involvement improves comparability and
standardization among the data presented by different in-
vestigators and has to be evaluated for its prognostic value
in the future.
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